Home

Installation do not do former cd38 macrophage marker metallic enable Claim

Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab  in Multiple Myeloma
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis
Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ  fibrosis - ScienceDirect
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis - ScienceDirect

Aging-related inflammation driven by cellular senescence enhances NAD  consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Frontiers | CD38: A Significant Regulator of Macrophage Function
Frontiers | CD38: A Significant Regulator of Macrophage Function

Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio

Senescent cells promote tissue NAD+ decline during ageing via the  activation of CD38+ macrophages | Nature Metabolism
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages | Nature Metabolism

IJMS | Free Full-Text | Dysregulated CD38 Expression on Peripheral Blood  Immune Cell Subsets in SLE
IJMS | Free Full-Text | Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE

CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews

Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis  in Hepatocellular Carcinoma
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

CD38 and other M1 markers in macrophages treated with SASP. (A)... |  Download Scientific Diagram
CD38 and other M1 markers in macrophages treated with SASP. (A)... | Download Scientific Diagram

CD38 promotes pristane-induced chronic inflammation and increases  susceptibility to experimental lupus by an apoptosis-driven and  TRPM2-dependent mechanism | Scientific Reports
CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism | Scientific Reports

Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in  Inflammatory Conditions
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Macrophage Immunometabolism and Inflammaging: Roles of Mitochondrial  Dysfunction, Cellular Senescence, CD38, and NAD
Macrophage Immunometabolism and Inflammaging: Roles of Mitochondrial Dysfunction, Cellular Senescence, CD38, and NAD

Frontiers | CD38: A Significant Regulator of Macrophage Function
Frontiers | CD38: A Significant Regulator of Macrophage Function

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts  responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma  | Journal for ImmunoTherapy of Cancer
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

Senescent cells promote tissue NAD+ decline during ageing via the  activation of CD38+ macrophages | Nature Metabolism
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages | Nature Metabolism

Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in  Inflammatory Conditions
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions

Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages. Flow... |  Download Scientific Diagram
Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages. Flow... | Download Scientific Diagram

Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE

CD38-expressing macrophages drive age-related NAD+ decline | Nature  Metabolism
CD38-expressing macrophages drive age-related NAD+ decline | Nature Metabolism